Publications

invasive group b streptococcal disease in adults. a population-based study in metropolitan atlanta.	to define the incidence and clinical spectrum of group b streptococcus infection in adults. to characterize groups at increased risk for infection.	1991	1865545
population-based risk factors for neonatal group b streptococcal disease: results of a cohort study in metropolitan atlanta.	to determine risk factors for neonatal group b streptococcal (gbs) disease, a cohort study was conducted in atlanta of infants with invasive gbs disease during 1982 and 1983. laboratory review detected 71 infants with early-onset disease (1.09 cases/1000 live births) and 37 infants with late-onset disease (0.57 cases/1000 live births). compared with the 64,858 births in atlanta in the same period, infants with early-onset gbs disease were more often black, less than 2500 g, and born to teenage m ...	1990	2201741
invasive group b streptococcal disease: the emergence of serotype v.	group b streptococci (gbs) cause invasive disease in neonates, pregnant adults, and nonpregnant adults with underlying or chronic disease. previous studies found capsular serotypes ia, ib, ii, and iii cause invasive disease. prospective population-based surveillance of invasive gbs disease was done from june 1992 to june 1993 in metropolitan atlanta: 279 patients had invasive disease. of these, 43% were < or = 6 months old, and 57% were adults. the incidence among all adults was 7.7/100,000/year ...	1996	8568297
decreasing incidence of perinatal group b streptococcal disease--united states, 1993-1995.	group b streptococcal (gbs) infections are the leading cause of bacterial disease and death among newborns in the united states and an important cause of morbidity among peripartum women and nonpregnant adults with chronic medical conditions. disease in infants usually presents as sepsis, pneumonia or meningitis but also may include cellulitis or osteomyelitis. in 1990, gbs infections caused an estimated 7600 serious illnesses and 310 deaths among u.s. infants aged < or = 90 days; infections amo ...	1997	9182211
laboratory practices for prenatal group b streptococcal screening and reporting--connecticut, georgia, and minnesota, 1997-1998.	group b streptococcus (gbs) is a leading cause of neonatal sepsis in the united states. cdc, in collaboration with the american college of obstetricians and gynecologists and the american academy of pediatrics, recommends that laboratories adopt optimal screening practices to identify gbs and to promptly report test results so that gbs-colonized pregnant women can receive antibiotics during labor. to assess gbs screening practices in clinical laboratories, state health departments surveyed labor ...	1999	10365633
trends in incidence and antimicrobial resistance of early-onset sepsis: population-based surveillance in san francisco and atlanta.	although increased use of intrapartum antibiotics caused significant declines in early-onset group b streptococcus (gbs) infection, the effect on infections caused by other pathogens is not clear. the objective of this study was to determine trends in the incidence of early-onset sepsis caused by organisms other than group b streptococcus in the era of antimicrobial prophylaxis.	2002	12359781